BiotechTube

HRG2010; Sustained-release Carbidopa/Levodopa administered placebo + Sustained-release Carbidopa/Levodopa; HRG2010 placebo

Phase 3Recruiting
0 views this week 0 watching⚡ Active🧠Featured in Neuroscience Pipeline Watch
Interest: 47/100
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Parkinson's Disease

Conditions

Parkinson's Disease

Trial Timeline

Nov 6, 2024 → Feb 14, 2027

NCT ID
NCT06596876

About HRG2010; Sustained-release Carbidopa/Levodopa administered placebo + Sustained-release Carbidopa/Levodopa; HRG2010 placebo

HRG2010; Sustained-release Carbidopa/Levodopa administered placebo + Sustained-release Carbidopa/Levodopa; HRG2010 placebo is a phase 3 stage product being developed by Jiangsu Hengrui Medicine for Parkinson's Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06596876. Target conditions include Parkinson's Disease.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson's Disease were approved

Approved (20) Terminated (3) Active (0)
✅Lemborexant + placeboEisaiApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved
✅carbidopa/levodopa + Carbidopa/Levodopa/EntacaponeNovartisApproved
✅carbidopa, levodopa, entacaponeNovartisApproved
✅Levodopa/carbidopa/entacapone + Levodopa/carbidopaNovartisApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06596876Phase 3Recruiting

Competing Products

20 competing products in Parkinson's Disease

See all competitors
ProductCompanyStageHype Score
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
GPI 1485EisaiPhase 2
35
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
E2007 + E2007 + E2007EisaiPhase 2
35
E2007EisaiPhase 2
35
E2007EisaiPhase 2
27
E2007EisaiPhase 2
27
2 mg perampanel + 4 mg perampanel + placebo comparatorEisaiPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 2
35
Istradefylline 20 mg or 40 mgKyowa KirinPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 3
40